Women heart failure advances

PLA General Hospital Professor Chen Yun-Dai in third national report of female heart failure congestive heart failure advances.has become a woman first coronary heart disease death killer, is 4~6 times the mortality rate of breast cancer mortality in women's heart disease. With the deepening of understanding, people find that either the acute ischemia or the chronic ischemia, pathophysiology, clinical manifestations and treatment effect, the apparent differences between men and women.study finds that older, little female higher incidence of cardiovascular events. In terms of compensation and reconstruction of congestive heart failure, myocardial compliance is not strong in women's overall, load capacity and pressure changed markedly, apoptosis of myocardial cells slows.cardiac protective effect of estrogen on women is not yet determined, the female hormone on myocardial protective effect of incomplete determination depends on the usual peripheral estrogen levels. Estrogen reduces myocardial cell injury under pathological conditions.for the treatment of left ventricular myocardial remodeling, not only drug treatment, such checks should also focus on ultrasound, magnetic resonance imaging results. On left ventricular remodeling of the treatment of non-drug treatment instead of treatment and stem cell transplantation and valve replacement, Surgical Ventricular remodeling is an effective method of treatment, changes in ventricular size and apical forming process, the above operation for both men and women have the same benefits.